EnginZyme to raise €21M in a Series B round backed by Bunge Ventures, Navigare Ventures, Sofinnova Partners, Almi, SEB GreenTech VC and Industrifonden.

Biotech Health services

Investments

16 December 2022

EnginZyme (company)

Biotech Health services

Total investments received (USD): 34.76m

Round value (USD): 22.27m

Round investors: Almi Invest Industrifonden SEB Venture Capital Sofinnova Partners Navigare Ventures Bunge Ventures Francesca Baillieu

Industry: Biotech Health services

Biotech Health services Manufacturing

Investments 31 May 2023

Biotech Health services

Investments 18 June 2022